AR033300A1 - Compuestos de cefem - Google Patents

Compuestos de cefem

Info

Publication number
AR033300A1
AR033300A1 ARP020101603A ARP020101603A AR033300A1 AR 033300 A1 AR033300 A1 AR 033300A1 AR P020101603 A ARP020101603 A AR P020101603A AR P020101603 A ARP020101603 A AR P020101603A AR 033300 A1 AR033300 A1 AR 033300A1
Authority
AR
Argentina
Prior art keywords
alkyl
amino
protected
compound
formula
Prior art date
Application number
ARP020101603A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR4690A external-priority patent/AUPR469001A0/en
Priority claimed from AUPR5834A external-priority patent/AUPR583401A0/en
Application filed by Fujisawa Pharmaceutical Co, Wakunaga Pharma Co Ltd filed Critical Fujisawa Pharmaceutical Co
Publication of AR033300A1 publication Critical patent/AR033300A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La presente se refiere a un compuesto de la formula (1), donde: A es alquileno inferior o alquenileno inferior; R1 es alquilo inferior, hidroxi alquilo (inferior), hidroxi alquilo (inferior) protegido, amino alquilo (inferior) o amino alquilo (inferior) protegido, y R2 es hidrogeno o grupo protector de amino, o R1 y R2 están unidos entre sí y forman alquileno inferior; R3 y R5 son independientemente amino o amino protegido; y R4 es carboxi o carboxi protegido, o una sal farmacéuticamente aceptable de éste, un procedimiento para preparar un compuesto de la formula (1), y una composicion farmacéutica que comprende un compuesto de la formula (1) mezclado con un soporte o vehículo farmacéuticamente aceptable.
ARP020101603A 2001-05-01 2002-04-30 Compuestos de cefem AR033300A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR4690A AUPR469001A0 (en) 2001-05-01 2001-05-01 Cephem compounds
AUPR5834A AUPR583401A0 (en) 2001-06-20 2001-06-20 Cephem compounds

Publications (1)

Publication Number Publication Date
AR033300A1 true AR033300A1 (es) 2003-12-10

Family

ID=25646666

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101603A AR033300A1 (es) 2001-05-01 2002-04-30 Compuestos de cefem

Country Status (19)

Country Link
US (1) US7179801B2 (es)
EP (1) EP1392704B1 (es)
JP (1) JP4251873B2 (es)
KR (1) KR20030090794A (es)
CN (1) CN1522259A (es)
AR (1) AR033300A1 (es)
AT (1) ATE318269T1 (es)
BR (1) BR0209452A (es)
CA (1) CA2446099A1 (es)
DE (1) DE60209341T2 (es)
ES (1) ES2254671T3 (es)
HU (1) HUP0304042A2 (es)
MX (1) MXPA03010002A (es)
NO (1) NO20034824L (es)
NZ (1) NZ529887A (es)
PL (1) PL366507A1 (es)
RU (1) RU2003134629A (es)
TW (1) TWI224599B (es)
WO (1) WO2002090364A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE368042T1 (de) * 2002-10-30 2007-08-15 Astellas Pharma Inc Cephemverbindungen
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
AR045768A1 (es) * 2003-09-18 2005-11-09 Fujisawa Pharmaceutical Co Compuestos de cefem y sus sales farmaceuticamente aceptables
ES2278353T3 (es) * 2003-10-28 2007-08-01 Schering Corporation Procedimiento para preparar 5-amino-pirazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pirimidinas sustituidas.
JPWO2005085258A1 (ja) * 2004-03-05 2007-12-13 塩野義製薬株式会社 ３−ピリジニウムメチルセフェム化合物
EP1994035A1 (en) * 2006-03-16 2008-11-26 Astellas Pharma Inc. Cephem compounds and use as antimicrobial agents
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104140427A (zh) * 2014-07-05 2014-11-12 湖南华腾制药有限公司 一种四氢吡唑并[1,5-a]嘧啶的制备方法
EP3347362B1 (en) * 2015-09-08 2019-10-23 Sandoz AG Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-aca)
CN107586305A (zh) * 2017-06-23 2018-01-16 浙江惠迪森药业有限公司 一种β‑内酰胺类化合物羧基及羟基保护基脱除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
US5210080A (en) * 1987-09-07 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
IE63094B1 (en) * 1987-09-14 1995-03-22 Fujisawa Pharmaceutical Co Cephem compound and a process for preparation thereof
US5173485A (en) * 1988-03-09 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Cephem compounds
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
KR910015587A (ko) * 1990-02-27 1991-09-30 후지사와 토모키치로 세펨 화합물
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) * 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
ATE368042T1 (de) * 2002-10-30 2007-08-15 Astellas Pharma Inc Cephemverbindungen
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
AR045768A1 (es) * 2003-09-18 2005-11-09 Fujisawa Pharmaceutical Co Compuestos de cefem y sus sales farmaceuticamente aceptables

Also Published As

Publication number Publication date
WO2002090364A1 (en) 2002-11-14
CN1522259A (zh) 2004-08-18
JP4251873B2 (ja) 2009-04-08
CA2446099A1 (en) 2002-11-14
DE60209341T2 (de) 2006-08-03
RU2003134629A (ru) 2005-06-10
EP1392704A1 (en) 2004-03-03
ES2254671T3 (es) 2006-06-16
HUP0304042A2 (hu) 2004-04-28
US7179801B2 (en) 2007-02-20
DE60209341D1 (de) 2006-04-27
KR20030090794A (ko) 2003-11-28
NZ529887A (en) 2005-05-27
EP1392704B1 (en) 2006-02-22
PL366507A1 (en) 2005-02-07
NO20034824L (no) 2003-12-29
ATE318269T1 (de) 2006-03-15
TWI224599B (en) 2004-12-01
US20040248875A1 (en) 2004-12-09
JP2004529172A (ja) 2004-09-24
MXPA03010002A (es) 2004-06-30
BR0209452A (pt) 2004-12-14
NO20034824D0 (no) 2003-10-29

Similar Documents

Publication Publication Date Title
AR033300A1 (es) Compuestos de cefem
AR045768A1 (es) Compuestos de cefem y sus sales farmaceuticamente aceptables
BR0315188A (pt) Composto de cefem
BR0014116A (pt) Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
AP2001002241A0 (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents.
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
IL154893A0 (en) Aliphatic nitrogen-containing cyclic compounds, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP9802814A2 (hu) Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
JPS55127384A (en) Novel chromone compound*its manufacture and drug composition containing it
MY114679A (en) Aroyl-piperidine derivatives
BR0111377A (pt) Derivados de tiofeno úteis como agentes anticancerìgenos
CO5070574A1 (es) Derivado del acido fenoxiacetico y composicion farmaceutica que lo contiene
AR040473A1 (es) Derivados de aminoalcoholes, un procedimiento de preparacion, composicion farmaceutica y uso del compuesto para preparar medicamentos
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
ES8306160A1 (es) "procedimiento para preparar un nuevo compuesto de cefem".
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
MX9604483A (es) Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
AR035728A1 (es) Proceso perfeccionado para la sintesis de carbapenem
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
AR044175A1 (es) Compuestos de cefemo
IL181888A0 (en) Aminoalcohol derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FB Suspension of granting procedure